Shattuck Labs, Inc.
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the trea…
Biotechnology
US, Austin [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Shattuck Labs, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDShattuck Labs, Inc. can't present revenue by segment